Clinical and sociodemographic characteristics of patients with kidney dysfunction or kidney transplant rejection
Article Sidebar
Main Article Content
Abstract
Introduction: The identification of clinical and sociodemographic characteristics of patients with kidney dysfunction or kidney transplant rejection can help the design and implementation of nursing interventions which contribute to the patient’s survival.
Objective: To describe the clinical and sociodemographic characteristics of patients suffering from kidney dysfunction or kidney transplant rejection in a 3rd level hospital in the city of Leon, Guanajuato, Mexico.
Methods: This is a retrospective and descriptive study using sampling by convenience. 118 clinical records of adult patients with a diagnosis of kidney dysfunction or kidney transplant rejection during the period 2016-2018 were identified. Clinical and sociodemographic data from both groups of patients were compared. A value of p< 0.05 was accepted as statistically significant.
Results: 20.3% of the total patients were diagnosed with kidney dysfunction and 79.7% with kidney transplant rejection. The mean patient age was 29.9 ± 10.2 years old with a range of 20 to 84. The majority of patients were male with a background of having received a kidney transplant from a deceased donor. No main differences in clinical and sociodemographic characteristics were found between the patients with kidney dysfunction and the patients with kidney transplant rejection.
Conclusions: Kidney dysfunction and kidney transplant rejection continue being frequent health problems, and a better knowledge of the clinical and sociodemographic characteristics of these patients, even if no main differences between the two groups are found, will contribute to the better design and implementation of the related nursing interventions.
Publication Facts
Reviewer profiles N/A
Author statements
- Editor & editorial board
- profiles
- Academic society
- N/A
- Publisher
- Universidad Nacional Autónoma de México
To learn about these publication facts, click 
PF is maintained by the Public Knowledge Project
Article Details
Dimensions citation
MÉTRICAS
References
2. Gonzalez-Bedat MC, Rosa-Diez G, Ferreiro A. El registro latinoamericano de diálisis y trasplante renal: la importancia del desarrollo de los registros nacionales en latinoamérica. Nefrol Latinoam. 2017; 14 (1): 12-21. https://doi.org/10.1016/j.nefrol.2016.12.002
3. Secretaría de Salud / Centro Nacional de Trasplantes. Reporte anual 2019 de donación y trasplantes en México. México: SSA / CENATRA; 2019. https://bit.ly/3mU1Txg
4. Günay E, Çelebi T, Şen S, Aşcı G, Sarsik Kumbaraci B, Gökalp C, et al. Investigation of the factors affecting allograft kidney functions: Results of 10 years. Transplant Proc. 2019; 51(4): 1082-5. https://doi.org/10.1016/j.transproceed.2019.02.014
5. Rebello-Bicalho P, Requião-Moura LR, Ferraz-Arruda É, Chinen R, Mello L, Bertocchi APF, et al. Long-term outcomes among kidney transplant recipients and after graft failure: A single-center cohort study in Brazil. Biomed Res Int. 2019. https://doi.org/10.1155/2019/7105084
6. Baker RJ, Marks SD. Management of chronic renal allograft dysfunction and when to re-transplant. Pediatr Nephrol. 2019; 34(4): 599-603. https://doi.org/10.1007/s00467-018-4000-9
7. Campistol JM, Gutiérrez-Dalmau A, Crespo J, Saval N, Grinyó JM, Grupo de Estudio Observa. Actitud clínica frente a la disfunción renal en receptores de un trasplante renal en España. Nefrología. 2015; 35(3): 256-63. http://dx.doi.org/10.1016/j.nefro.2015.05.006
8. Seija M, Nin M, Astesiano R, Coitiño R, Santiago J, Ferrari S, et al. Rechazo agudo del trasplante renal: diagnóstico y alternativas terapéuticas. Nefrol Latinoam. 2017; 4(4): 119-30. https://doi.org/10.1016/j.nefrol.2017.10.001
9. Etta PK, Rao MV. Renal allograft dysfunction: An update on immunological graft injury. Indian J Transplant. 2019; 13(2): 69‑77. https://doi.org/10.4103/ijot.ijot_84_18
10. Moreso F, Hernández D. ¿Ha mejorado la supervivencia del injerto tras el trasplante renal en la era de la moderna inmunosupresión? Nefrología. 2013; 33(1): 14-26. https://doi.org/10.3265/Nefrologia.pre2012.Oct.11739
11. Ruiz-Calzado MR. La adherencia terapéutica en el paciente trasplantado renal. Enferm Nefrol. 2013; 16(4): 258-70. http://dx.doi.org/10.4321/S2254-28842013000400007
12. Durán-Muñoz MI, Lope-Andrea T, del Pino-Jurado MR, Chicharro-Chicharro MC, Matilla-Villar E. Adherencia al tratamiento inmunosupresor en el paciente adulto con trasplante renal. Enferm Nefrol. 2013; 15(4): 300–5. http://dx.doi.org/10.4321/S2254-28842012000400010
13. Magott-Procelewska M, Boratyńska M, Madziarska K, Chudoba P, Klinger M. Impaired kidney allograft: How long can it function? A single-center study of the transplantation population. Transplant Proc. 2014; 46(8): 2692-5. https://doi.org/10.1016/j.transproceed.2014.08.022
14. Mahendran AO, Barlow AD. Kidney transplantation. Surgery. 2014; 32(7): 364-70. https://doi.org/10.1016/j.mpsur.2014.04.010
15. Haas M, Loupy A, Lefaucheur C, Roufosse C, Glotz D, Seron D, et al. The Banff 2017 kidney meeting report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials. Am J Transplant. 2018; 18(2): 293-307. https://doi.org/10.1111/ajt.14625
16. Asociación Médica Mundial. Declaración de Helsinki de la AMM-Principios éticos para las investigaciones médicas en seres humanos. Riesgos , costos y beneficios. Francia: AMM; 2017.
17. Secretaría de Salud. Reglamento de la Ley General de Salud en materia de investigación para la salud. México: DOF; Última reforma 2014.
18. Gorayeb-Polacchini FS, Caldas HC, Gauch CR, Ferreira-Baptista MAS, Fernandes-Charpiot IMM, Abbud-Filho M. Factors that influence delayed graft function in kidney transplants: A single-center paired kidney analysis. Transplant Proc. 2019; 51(5): 1568-70. https://doi.org/10.1016/j.transproceed.2019.01.040
19. Hansson J, Mjörnstedt L, Lindnér P. The risk of graft loss 5 years after kidney transplantation is increased if cold ischemia time exceeds 14 hours. Clin Transplant. 2018; 32(9): 1-27. https://doi.org/10.1111/ctr.13377
20. Gong L, Wang K. Research progress on preventions of ischemia-reperfusion injury during kidney transplant. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2018; 35(5): 817-21. https://doi.org/10.7507/1001-5515.201804009
21. Stolyar AG, Tomilina NA. Impact of smoking on kidney transplantation outcomes. Ter Arkh. 2016; 88(12): 45-50. https://doi.org/10.17116/terarkh2016881245-50
22. Erturk T, Berber I, Cakir U. Effect of obesity on clinical outcomes of kidney transplant patients. Transplant Proc. 2019; 51(4): 1093-5. https://doi.org/10.1016/j.transproceed.2019.02.012
23. Liese J, Bottner N, Büttner S, Reinisch A, Woeste G, Wortmann M, et al. Influence of the recipient body mass index on the outcomes after kidney transplantation. Langenbecks Arch Surg. 2018; 403(1): 73-82. https://doi.org/10.1007/s00423-017-1584-7
24. Tzvetanov I, D’Amico G, Walczak D, Jeon H, Garcia-Roca R, Oberholzer J, et al. High rate of unemployment after kidney transplantation: Analysis of the united network for organ sharing database. Transplant Proc. 2014; 46(5): 1290-4. http://dx.doi.org/10.1016/j.transproceed.2014.02.006
25. Pistorio ML, Veroux M, Trigona C, Patanè M, Lo Bianco S, Cirincione G, et al. Psychological and Emotional Aspects in Living Donor Kidney Transplantation. Transplant Proc. 2019; 51(1): 124-7. https://doi.org/10.1016/j.transproceed.2018.04.085
26. Hamza WM, Ali HH, Gabal SM, Fadda SA. Chronic renal allograft dysfunction in Egyptian population: Histopathological and immunohistochemical Study. Saudi J Kidney Dis Transpl. 2016; 27(5): 921-8. https://doi.org/10.4103/1319-2442.190818
27. González-Posada Delgado JM, Pérez-Tamajón L, Marrero-Miranda D, Rodríguez-Hernández A, Delgado-Mallén P, Álvarez-González A, et al. Nefrología al día. Complicaciones médicas precoces tras el trasplante renal. Barcelona: Sociedad Española de Nefrología (S.E.N.); 2016. https://bit.ly/32b6OSw
28. Melih KV, Boynuegri B, Mustafa C, Nilgun A. Incidence, risk factors, and outcomes of delayed graft function in deceased donor kidney transplantation. Transplant Proc. 2019; 51(4): 1096-100. https://doi.org/10.1016/j.transproceed.2019.02.013
29. Muth BL, Astor BC, Turk J, Mohamed M, Parajuli S, Kaufman DB, et al. Outpatient management of delayed graft function is associated with reduced length of stay without an increase in adverse events. Am J Transplant. 2016; 16(5): 1604–11. https://doi.org/10.1111/ajt.13689
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Enfermería Universitaria by Universidad Nacional Autónoma de México it is distributed under the License Creative Commons Attribution - NonCommercial - NoDerivatives 4.0 International
Accepted and published articles become open-access under the terms of the Creative Commons CC BY-NC-ND 4.0 license, which authorizes the reproduction and sharing without commercial purposes, provided the corresponding acknowledgments to their authors. Authors are allowed to manage a self-archive copy of the article’s published version so that they can open-access it in their personal or institutional web pages, and/or any other broad-diffusion space.
